Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HCA vs GSK✓SelectedUSD · GSKHCA vs GSK performance historyLatest closeAs of-2.07%11/17
Stock and ETF performance explorer

HCA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+106.4%
GSK return
+58.1%
Excess return
+48.3%
Maximum drawdown
-33.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.1%-2.3%+0.3%-1.3%
7D-0.6%-3.0%+2.4%+0.4%
30D+9.2%+0.4%+8.9%+9.1%
3M+24.0%-1.2%+25.2%+24.2%
6M+18.9%+0.9%+18.0%+18.7%
YTD+7.9%+4.0%+3.9%+6.5%
1Y+5.8%+7.3%-1.5%+3.3%
All+106.4%+58.1%+48.3%+70.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling